Pharmaceutical Technology-07-02-2011

i2-729993-1408615186282.gif

FDA, in cooperation with IPEC, is building a spectral library of excipients to detect improper ingredients within a drug product on site.

The performance of biotechnology venture capital and investment is lackluster at best.

Getting an answer is easy-asking the right question is apparently more difficult.